Stockscreener 앱 받기
0.3733
14.83%
0.0482
전일 마감가:
$0.3251
열려 있는:
$0.3675
하루 거래량:
3.11M
Relative Volume:
10.60
시가총액:
$55.01M
수익:
-
순이익/손실:
$-54.17M
주가수익비율:
-1.0092
EPS:
-0.3699
순현금흐름:
$-39.34M
1주 성능:
+2.30%
1개월 성능:
-5.09%
6개월 성능:
-86.47%
1년 성능:
-77.51%
1일 변동 폭
$0.355
$0.405
1주일 범위
$0.325
$0.405
52주 변동 폭
$0.2928
$3.5299
Immutep Limited Adr Stock (IMMP) Company Profile
Compare IMMP vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
0.3733 | 55.01M | 0 | -54.17M | -39.34M | -0.3699 |
VRTX
Vertex Pharmaceuticals Inc
|
515.44 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
781.49 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.39 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
143.97 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.77 | 43.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-13 | 다운그레이드 | Citizens | Mkt Outperform → Mkt Perform |
| 2026-03-13 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2026-03-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2026-02-17 | 개시 | Citizens | Mkt Outperform |
| 2024-05-17 | 개시 | CapitalOne | Overweight |
| 2023-08-03 | 개시 | Robert W. Baird | Outperform |
| 2021-08-03 | 개시 | Ladenburg Thalmann | Buy |
| 2021-07-16 | 재개 | Maxim Group | Buy |
| 2018-09-28 | 개시 | B. Riley FBR | Buy |
| 2018-02-15 | 재확인 | Maxim Group | Buy |
모두보기
Immutep Limited Adr 주식(IMMP)의 최신 뉴스
Immutep (NASDAQ: IMMP) halts Phase III lung cancer trial and returns cash to Dr Reddy’s - stocktitan.net
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming DeadlinesIMMP - Eastern Progress
Immutep Ltd Sponsored ADR Revenue Breakdown – FWB:YP1A - TradingView
Immutep Ltd Sponsored ADR Revenue Breakdown – MUN:YP1A - TradingView
What Triggered Immutep's Securities Class Action Lawsuit - Kavout | AI
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight - GlobeNewswire Inc.
Immutep (ASX:IMM) Shares Surge Nearly 14% as Healthcare Momentum Grabs the ASX Spotlight - Kalkine
IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com
Immutep Limited Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsIMMP - Finansavisen
YP1A Forecast — Price Target — Prediction for 2027 - TradingView
Class action lawsuit filed against Immutep afte... - Pluang
A2H8YL Forecast — Price Target — Prediction for 2027 - TradingView
IMMP Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
IMMP Deadline Alert: Levi & Korsinsky Reminds Immutep Limited (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - PR Newswire
IMMP Investor AlertImmutep Limited Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit - Morningstar
IMM:ASX AnnouncementChange in substantial holding09 Jun 2026 - Market Index
IMMP UPCOMING DEADLINE: Levi & Korsinsky Alerts Immutep Limited Stockholders of Securities Class Action - GlobeNewswire Inc.
symbol__ Stock Quote Price and Forecast - CNN
רוזן, יועץ למשקיעים מוביל, מעודד את משקיעי Immutep Ltd. לקבל ייעוץ משפטי לפני מועד אחרון חשוב בתביעה ייצוגית לניירות ערך - GlobeNewswire Inc.
IMMP Investors Have Opportunity to Lead Immutep Ltd. Securities Fraud Lawsuit - Morningstar
IMMP DEADLINE: Levi & Korsinsky Reminds Immutep Limited Investors of Upcoming Securities Class Action Deadline - Finansavisen
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Immutep Ltd. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
IMMP Shareholder Alert: Immutep Limited Securities Class Action LawsuitInvestors With Losses May Contact The Gross Law Firm - Finansavisen
IMMP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - TMX Newsfile
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel ... - Caledonian Record
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Immutep Limited (IMMP): Firm Reports Positive Data from Trials - Finviz
SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026IMMP - Barchart
ROSEN, A RANKED AND LEADING FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, A RANKED AND LEADING FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
IMMP Stock Price, Quote & Chart | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
IMMP Shareholder Alert: July 6, 2026 Lead Plaintiff Deadline in Immutep Limited Securities Class ActionContact The Gross Law Firm - Barchart.com
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Pomerantz LLP Highlights Legal Filing Against Immutep Limited – IMMP - ACCESS Newswire
Immutep Limited Adr (IMMP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
1.67%
자본화:
|
볼륨(24시간):